Foundayo
Generic name: orforglipron
- How it's taken
- Tablet, once daily, with or without food
- FDA-approved for
- Chronic weight management in adults with obesity, or overweight plus at least one weight-related condition, with a reduced-calorie diet and more physical activity.
- Good to know
- FDA-approved April 2026. A small-molecule (non-peptide) GLP-1 receptor agonist that can be taken any time of day without food or water restrictions. Carries the same thyroid C-cell tumor warning as other GLP-1s.
Read more: Which GLP-1 Medications Are FDA-Approved for Weight Loss? (2026 Guide) · GLP-1 Pills vs Injections: How Do They Compare?